New Role Management Nasopharyngeal Carcinoma Patient in General Hospital Haji Adam Malik Medan during COVID-19 Pandemic

Authors

  • Sholahuddin Adlan Simatupang 1Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Farhat Farhat Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Elvita Rahmi Daulay Departement of Radiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.32734/ijnpc.v3i02.6320

Keywords:

Nasopharyngeal Carcinoma, management, COVID-19, Adam Malik

Abstract

Introduction:

Nasopharyngeal carcinoma (NPC) is a type of squamous cell carcinoma that develops from the nasopharyngeal epithelial cells and has become one among the most popular frequent malignancy in the head and neck. When patients with cancer are diagnosed with COVID-19, more intense surveillance or treatment should be considered.

Discussion:

In the COVID 19 pandemic, Personal protection provisions should be strengthened. created for cancer patients and cancer survivors. To avoid the spread of COVID-19, many improvements have been made in the treatment of NPC patients at the Haji Adam Malik General Hospital in Medan.

Conclusion:

The management carried out on NPC patients, there are several examinations that the patient needs to do first in the COVID 19 pandemic at the General Hospital Haji Adam Malik Medan

Downloads

Download data is not yet available.

References

Yavuz A, Ağralı ÖB, Çalışkan ZL, Türkaydın D, Sertgöz A, Kuru B, Doğan B. Multidisciplinary treatment approach in a patient with history of nasopharyngeal carcinoma. Case reports in dentistry. 2014 Jan 9;2014. DOI: https://doi.org/10.1155/2014/918461

Svajdova M, Sicak M, Dubinsky P, Slavik M, Slampa P, Kazda T. Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic. Cancers. 2020 Dec;12(12):3510. DOI: https://doi.org/10.3390/cancers12123510

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018 Nov;68(6):394-424. DOI: https://doi.org/10.3322/caac.21492

Barnes L, Eveson JW, Reichart P, Sidransky D. (Eds.) Pathology and genetics of head and neck tumors. In World Health Organization Classification of Tumours; 2005. IARC Press: Lyon, France; pp. 81–83.

De Luca P, Bisogno A, Colacurcio V, Marra P, Cassandro C, Camaioni A, Cassandro E, Scarpa A. Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect?. European Archives of Oto-Rhino-Laryngology. 2021 Apr 30:1-5. DOI: https://doi.org/10.1007/s00405-021-06834-1

Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments. The Lancet Infectious Diseases. 2020 Apr 1;20(4):400-2. DOI: https://doi.org/10.1016/S1473-3099(20)30132-8

De Luca P, Scarpa A, Ralli M, De Vincentiis M, Cassandro E, Chiarella G, Cassandro C. Nasal, pharyngeal and laryngeal endoscopy procedures during COVID-19 pandemic: available recommendations from national and international societies. European Archives of Oto-Rhino-Laryngology. 2020 Jul;277:2151-3. DOI: https://doi.org/10.1007/s00405-020-06028-1

La Rosa G, Mancini P, Ferraro GB, Veneri C, Iaconelli M, Bonadonna L, Lucentini L, Suffredini E. SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring. Science of the total environment. 2021 Jan 1;750:141711. DOI: https://doi.org/10.1016/j.scitotenv.2020.141711

Veccia A, Kinspergher S, Dispasquale M, and Caffo O. Nasopharyngeal Swab or Clinical-Radiological Evidence: The Dark Side of The Moon for Cancer Patients in The COVID-19 Era. Future Medicine. 2020 : 72:1-2. DOI: https://doi.org/10.2217/fon-2020-0372

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The lancet oncology. 2020 Mar 1;21(3):335-7. DOI: https://doi.org/10.1016/S1470-2045(20)30096-6

Stoker SD, Wildeman MA, Fles R, Indrasari SR, Herdini C, Wildeman PL, van Diessen JN, Tjokronagoro M, Tan IB. A prospective study: Current problems in radiotherapy for nasopharyngeal carcinoma in Yogyakarta, Indonesia. PLOS one. 2014 Jan 23;9(1):e85959. DOI: https://doi.org/10.1371/journal.pone. 0085959

Liang H, Xiang YQ, Lv X, Xie CQ, Cao SM, Wang L, Qian CN, Yang J, Ye YF, Gan F, Ke LR. Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area. European Journal of Cancer. 2017 Mar 1;73:48-60. DOI: https://doi.org/10.1016/j.ejca.2016.12.009

Chen YP, Mao YP, Zhang WN, Chen L, Tang LL, Li WF, Liu X, Zhou GQ, Guo R, Sun Y, Kang TB. Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensitymatched analysis. Oncotarget. 2016 Mar 22;7(12):14973. DOI: https://doi.org/10.18632/oncotarget.7789

Stoker SD, Fles R, Herdini C, Rijntjes FJ, Tjokronagoro M, Dwidanarti SR, Sikorska K, Leemans CR, Schmidt MK, Al-Mamgani A, Wildeman MA. The impact of the overall radiotherapy time on clinical outcome of patients with nasopharyngeal carcinoma; a retrospective study. PloS one. 2016 Mar 31;11(3):e0151899. DOI: https://doi.org/10.1371/journal.pone.0151899

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine. 2020 Mar 19;382(12):1177-9.. DOI: https://doi.org/10.1056/NEJMc2001737

Chow VL, Chan JY, Wong ST, Wei WI. Recommendations for surgical management of recurrent nasopharyngeal carcinoma during COVID‐19 pandemic. Laryngoscope Investigative Otolaryngology. 2020 Jun;5(3):468-72. DOI: https://doi.org/10.1002/lio2.417

World Health Organization. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19): interim guidance, 19 March 2020. World Health Organization; 2020.

Centers for Disease Control and Prevention (CDC). Healthcare Infection Control Practices Advisory Committee (HICPAC). Part III. Precautions to Prevent Transmission of Infectious Agents. 2019.

Centre for Health Protection. Key Elements on Prevention and Control. of Coronavirus Disease (COVID-19) in Healthcare Settings (Interim). 2020.

Achard V, Tsoutsou P, Zilli T. Letter from Switzerland. International Journal of Radiation Oncology, Biology, Physics. 2020 Jul 1;107(3):600. DOI: https://doi.org/10.1016/j.ijrobp.2020.03.008

Simcock R, Thomas TV, Estes C, Filippi AR, Katz MS, Pereira IJ, Saeed H. COVID-19: Global radiation oncology’s targeted response for pandemic preparedness. Clinical and translational radiation oncology. 2020 May 1;22:55-68. DOI: https://doi.org/10.1016/j.ctro.2020.03.009

Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R. Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. International Journal of Radiation Oncology Biology Physics. 2020 Jul 15;107(4):618-27. DOI: https://doi.org/10.1016/j.ijrobp.2020.04.016

Thomson DJ, Yom SS, Saeed H, El Naqa I, Ballas L, Bentzen SM, Chao ST, Choudhury A, Coles CE, Dover L, Guadagnolo BA. Radiation fractionation schedules published during the COVID-19 pandemic: A systematic review of the quality of evidence and recommendations for future development. International Journal of Radiation Oncology Biology Physics. 2020 Aug 11. DOI: https://doi.org/10.1016/j.ijrobp.2020.06.054

Yang Y, Shen C, and Hu C. Effect of COVID-19 Epidemic on Selay Diagnosis and Treatment Path for Patients with Nasopharyngeal Carcinoma. Cancer Management and Research. 2020: 12: 3859-3864. DOI: https://doi.org/10.2147/CMAR.S25409310.2147/CMAR.S254093

Liu SL, Sun XS, Yan JJ, Chen QY, Lin HX, Wen YF, Guo SS, Liu LT, Xie HJ, Tang QN, Liang YJ. Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response. Radiotherapy and Oncology. 2019 Aug 1;137:83-94.. DOI: https://doi.org/10.1016/j.radonc.20 19.04.020.

Ou X, Zhou X, Shi Q, Xing X, Yang Y, Xu T, Shen C, Wang X, He X, Kong L, Ying H. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost. Oncotarget. 2015 Nov 10;6(35):38381. DOI: https://doi.org/10.18632/oncotarget.5420.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The lancet oncology. 2020 Mar 1;21(3):335-7. DOI: https://doi.org/10.1016/S1470-2045(20)30096-6.

Published

2021-06-20

How to Cite

1.
Simatupang SA, Farhat F, Daulay ER. New Role Management Nasopharyngeal Carcinoma Patient in General Hospital Haji Adam Malik Medan during COVID-19 Pandemic. IJNPC [Internet]. 2021Jun.20 [cited 2022Aug.15];3(02):51-3. Available from: https://talenta.usu.ac.id/IJNPC/article/view/6320